Major Bleeding During Anticoagulation after Cerebral Ischemia, Patterns and Risk Factors
Neurol 53:1319-1327, Gorter,J.W., 1999
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999
Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999
Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999
Disturbance of Cerebral Function in People Exposed to Drinking Water Contaminated with Aluminum Sulphate:Retrospective Study of the Camelford Water Incident
BMJ 319:807-811, Altmann,P.,et al, 1999
Moderate Hypothermia for Uncontrolled Intracranial Hypertension in Acute Liver Failure
Lancet 354:1164-1168, Jalan,R.,et al, 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Neurologic Complications of Pediatric Lung Transplantation
Neurol 53:1542-1549, Wong,M.,et al, 1999
Edema Associated with Calcified Lesions in Neurocysticercosis
Neurol 53:777-781, Nash,T.E.&Patronas,N.J., 1999
Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999
Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999
Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999
Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999
When Should Heparin be Given to Patients with Atrial Fibrillation-Related Embolic Brain Infarcts?
Arch Neurol 56:1059-1060, Caplan,L.R., 1999
Heparin in Acute Stroke with Atrial Fibrillation, Clinical Relevance of Very Early Treatment
Arch Neurol 56:1098-1102,1059, Chamorro,A.,et al, 1999
Is There Still a Role for Intravenous Heparin in Acute Stroke? Yes
Arch Neurol 56:1159-1160,1162, Grau,A.J.&Hacke,W., 1999
Is There Still a Role for Intravenous Heparin in Acute Stroke? No
Arch Neurol 56:1160-1162, Sandercock,P., 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999
Neurologic Complications in Children with Enterovirus 71 Infection
NEJM 341:936-942, Huang,C-C.,et al, 1999
Thrombotic Thrombocytopenic Purpura:Brain CT and MRI Findings in 12 Patients
Neurol 52:1285-1288, Bakshi,R.,et al, 1999
Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999
Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999
Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999
Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999
Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999
Antiplatelet Therapy in Acute Cerebral Ischemia
Stroke 30:887-893, Bednar,M.M.&Gross,C.E., 1999
Hemorrhage After an Acute Ischemic Stroke
Stroke 30:761-764, Motto,C.,et al, 1999
Risk of Primary Intracerebral Haemorrhage Associated with Aspirin and Non-Steroidal Anti-Inflammatory Drugs:Case-Control Study
BMJ 318:759-764, Thrift,A.G.,et al, 1999
Carotid Artery Tandem Lesions:Frequency of Angiographic Detection and Consequences for Endarterectomy
AJNR 20:621-625, Rouleau,P.A.,et al, 1999
Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999
The Effect of Estrogen Replacement on Early Parkinson's Disease
Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999
Brain Tumors in Children
Arch Neurol 56:421-425, Packer,R.J., 1999
Current Treatment of Oligodendrogliomas
Arch Neurol 56:434-436, Perry,J.R.,et al, 1999
Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999
Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999
Prevention of Postherpetic Neuralgia
Lancet 353:1636-1637, Dworkin,R.H., 1999
Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999
Contrast Agent Neurotoxicity Presenting as Subarachnoid Hemorrhage
Neurol 52:1503-1505, Sharp,S.,et al, 1999
Intravenous Heparin for Acute Stroke, What Can We Learn from the Megatrials?
Neurol 52:1746-1750, Swanson,R.A., 1999
Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999